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IMMUNOREACTANTS AND CELLULAR CHANGES IN SERIAL BIOPSIES 
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To study the mechanisms responsible for leukocytoclastic vasculitis, we evaluated the 
kinetics of immunologic and cellular changes in induced vasculitis lesions. In four of five 
consecutive patients with active vasculitis, lesions were induced by increasing vascular 
permeability via injecting histamine into the skin. Biopsies were obtained for light and 
electron microscopy and immunofluorescence at 1, 4, 8, and 24 hr after injection. The 
results show that immunoglobulin, C3, and electron-dense material are deposited in vessel 
walls early and are followed by cellular infUtration . The characteristics of the cellular 
infiltrates were quite diverse at different times after histamine provocation and no 
distinctive patterns were seen. Nevertheless, the kinetics of the appearance ofimmunoreac-
tants and cells implies that immunoglobulin and probably circulating immune complexes 
are present prior to the development of inflammation and supports the contention that 
deposition of immune complexes within vessel walls is responsible for leukocytoclastic 
vasculitis. 
Leukocytoclastic vasculitis (LCV) is a patholog-
ical diagnosis whose features include infutration 
of neutrophils and mononuclear cells in and 
around postcapillary venules, leukocytoclasis (nu-
clear dust), hemorrhage. and necrosis of blood 
vessels occasionally leading to thrombosis 11,2). 
The cutaneous hallmark and most common pre-
senting sign of LCV is palpable purpura on the 
lower extremities 13). However, patients with 
palpable purpura a lso frequently have arthritis, 
gastrointestinal symptoms, and renal involve-
ment f 1 ,4]. Leukocytoclastic vasculitis occurs in 
association with a number of clinical situations 
including streptococcal infections l5,6.7 .8}, sys-
temic lupus erythematosus !SLE) [9] . rheumatoid 
arthritis rRA] f 10, 11], Henoch-Schonlein purpura 
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[12,13), mixed cyroglobulinemia [14 ,15), hypocom-
plementemic vasculitis 116). and hepatitis B dis-
ease 117 .18]. LCV may also occur secondary to a 
number of drugs and chemicals 14). 
The presumed pathogenesis of LCV is the for-
mation of circulating antigen-antibody complexes 
and their deposition in small blood vessels, fol-
lowed by inflammation. This presumption is based 
on the following: (1) circulating immune com-
plexes are involved in many of the above-men-
tioned syndromes (e.g., SLE. RAJ where LCV 
occurs; (2) the pathological features of LCV closely 
resemble those seen in the Arthus phenomenon, 
where the interaction of antigen and antibody, 
followed by complement activation, leads to in-
flammatory changes in vessels 119); (3) immuno-
reactants such as immunoglobulin (lgl and com-
plement (C) have been found in the lesions of 
LCV 120,21,22). 
Nevertheless, the relation between circulating 
immune complexes and vasculitis is not entirely 
clear. First, many (if not most) patients with LCV 
do not have the above-mentioned clinical syn-
dromes (e.g., SLE, RA, hepatitis B infection, etc.) 
and their vasculitis is often cal led "idiopathic." 
Second, measurements suggesting the presence of 
circulating immune complexes, such as low serum 
complement, are usually normal in idiopathic 
LCV (23). Third, immunoreactants such as lg and 
C are often not found in the lesions of idiopathic 
LCV. One reason for this might be that the 
immunoreactants may have been searched for in 
"old" lesions. Experimental evidence indicates 
that immunoreactants disappear 18-48 hr after 
lesion induction 124,25J. Finally, the presence of 
immunoreactants in LCV may be the result rather 
than the cause of vascular inflammation. 
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In order to explore these questions, we designed 
a protocol to induce lesions in patients with known 
LCV and to study the kinetics of the appearance 
of immunoreactants and inflammatory changes at 
known times after the lesions were induced. We 
took advantage of studies in experimental serum 
sickness in guinea pigs 126,27] and rabbits l28] 
and in spontaneous vasculitis in man 129], indicat-
ing that deposition of circulating soluble immune 
complexes in tissues is facilitated by local in-
creases in vascular permeability induced by vaso-
active amines. Translating this into the clinical 
situation, we injected histamine intracutaneously 
into a number of sites and performed serial skin 
biopsies. The biopsies were evaluated by light 
and electron microscopy and by direct immunoflu-
orescence (IF). Our results show that, Ig and C are 
deposited early and are followed by a progressive 
cellular infiltration including mononuclear cells 
(predominantly lymphocytes) and polymorphonu-
clear leukocytes (neutrophils). 
MATE~SAND~ffiTHODS 
Patients 
Five consecutive patients with clinical and his tolog-
ical evidence for idiopathic leukocytoclastic vasculitis 
were studied (Table 1). The time (days) between the 
onset of spontaneous lesions and biopsy of a lesion is 
listed. The criteria used to establish the diagnosis were 
as follows. Vasculitis was deftned as inflammation in 
small blood vessel walls other than in areas of severe 
tissue inflammation. If vascular necrosis was also pres-
ent, it was called necrotizing vasculitis. Leukocyto-
clasis (LCC) was defined as perivascular fragmented 
nuclei ; fragments in a reas of diffuse tissue necrosis 
were not counted as leukocytoclasis. 
Serum total hemolytic complement and complement 
components were determined in ihe 5 patients. 
Controls 
Three healthy adult male volunteers were studied. 
Informed consent was obtained from all 8 subjects. 
H istamine Prouocatwn 
Attempts to induce lesions were made by injecting 
0.55 1-tg histamine phosphate (Eli Lilly, Indianapolis, 
Indiana) in 0.02 ml sterile water intradermally into 4 
sites of the lower extremities. 
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Histamine Provocation Protocol. 
Using 1% lidocaine without epinephrine, punch biop-
sies were obtained from the lower extremities of each 
patient from normal-appearing skin (0 hr) and after 
histamine injection. Biopsy of a histamine-injected site 
was performed after 1, 4, 8, and 24 hr. In the normal 
controls, biopsies were done at 0, 1, and 4 hr only. All 
specimens were bisected. Half of each specimen was 
placed immediately into liquid nitrogen and stored at 
- 1o•c for immunofluorescent study and the other half 
fixed in glutaraldehyde. 
Spontaneous lesions were biopsied and processed as 
above for immunofluorescent study. The other half was 
further divided and placed in glutaraldehyde for elec-
tron microscopy (EM) studies and formaldehyde for 
staining with hematoxylin and eosin (H & E). 
Immunofluorescence (JF). 
Direct IF staining of skin biopsy specimens was 
performed using monospecific fluorescein-conjugated 
antisera to lgG, lgA, lgM, and C3 obtained from 
Hyland Laboratories, Costa Mesa, California. Immu-
nofluorescent studies were performed the same day on 
all specimens from each patient. Immunofluorescence 
was interpreted by one observer and read on a scale of 
0-4 + . Molar ratios of fluorescein to protein for these 
conjugated antisera were 2.4 (lgGl, 3.0 (!gAl, 3.3 (lgM), 
and 2.3 (C3). 
The cryostat tissue sections of 4 f.A. each were air-
dried before being overlaid for 30 minutes with an 
antiserum in a humidified chamber at room tempera-
ture. Sections were washed with phosphate-buffered 
saline, pH 7 .4, for 10 minutes after the application of 
each antiserum befm·e viewing with a Zeiss micrul;cope 
equipped with a quartz-halogen bulb and using a BG-
12 primary filter and an 0-53 light yellow secondary 
filter. 
Light and Electron. Microscopy (EM; 
Specimens were fixed in 4%- glutaraldehyde buffered 
with 0.1 M phosphate to pH 7.3. The material was 
postfixed with 2% osmium tetroxide, dehydrated 
through a graded series of alcohols and embedded in 
capsules containing Spurr medium. After embedding, 
5 capsules having both epidermis and dermis were 
selected for sectioning from each patient. 
"Thick" sections (0.5 f.A.) were stained for light micros-
copy with Azure II, methylene blue, and basic fuschin 
(30]. Four to five sections from each capsule were 
placed on a microscope slide, the most representative 
section from each capsule was selected, and at least 
three oil immersion fields (01F) were examined. There-
TABLE I. Clinical and histological characteristics of spontaneous lesions in. study patients 
Age Duration of Pt Sex 1'ype of lesions lesions Associated findings Histologic diagnosis (_vrsJ (days) 
A 21 F Palpable purpura 3 Pruritus, arthralgias. periarticular Necrotizing vascu-
swelling of hands and feet litis 
B 56 M Urticaria 120 Pruritus. transient and tender le- Vasculitis 
sions 
c 28 F Palpable purpura 12 Pruritis, tenosynovitis of ankles & Necrotizing vascu-
wrists litis 
D 52 M Palpable purpura 7 Pruritus, periarticular swelling of Necrotizing vascu-
ankles litis 
E 58 F Palpable purpura 7 Pruritis, arthralgias, and periarti- Vasculitis 
cular swelling of ankles 
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TABLE n. Histologic evaluation of0.5 J.L sections 
Mononuclear Cells Neutrophils or RBCs Fibrin Leukocytoclasis 
Cells per oil 
field Value 
Cells per 
oil field Value Amount per oil field Value 
Nuclear frag-
ments r,er oil Value 
fie d 
0 0 None 0 0 0 
1-2 + Few strands ... 1-2 + 
0-2 
3-4 
5-8 
0 
+ 
++ 
+++ 
3-4 ++ Moderate perivascular ++ 3-4 ++ 
> 8 5-8 +++ Moderate perivascular and in- +++ 5-8 +++ 
terstitial 
>8 ++++ Heavy perivascular and intersti- ++++ >8 ++++ 
tial 
fore, at lea§t 15 OIF per patient were evaluated. An 
estimate of cell number, LCC, and fibrin deposition 
was obtained using the criteria shown in Table ll. The 
results from the 5 capsules were averaged. 
"Thin" sections (70 run) were obtained from 1 or 2 
representative capsules and were double contrasted 
with uranyl acetate and lead citrate and viewed with a 
Phillips 300 electron microscope. Particular attention 
was paid to blood vessel morphology, cellular identifi-
cation, and a search for electron-dense deposits CEddl. 
Because of the limited area examined with the electron 
microscope, no quantitation was attempted; rather, the 
presence or absence of a particular variable was scored . 
RESULTS 
General Observations 
Patients D and E developed palpable purpura 
in the induced wheal 4 hr after histamine injec-
tion, and this purpura remained palpable for 24 
hr. The other 3 patients and the 3 controls showed 
no visible changes after histamine other than a 
transient wheal-and-flare reaction. 
Serum total hemolytic complement (CH50) levels 
were not depressed in any of the 5 patients (nl. 
range = 33-61 units: pt. A = 46, pt. B = 55, pt. 
C = 68, pt. D = 52, pt. E = 42). Individual meas-
urements of C3, C4, C5, and properdin were nor-
mal in each patient except that pt. D had a slight 
decrease in properdin and pt. E had a slight de-
crease in C4. 
ln[Za.mmatory Changes Seen by Light Microscopy 
Patients. The sequential changes of cellular 
infiltration, LCC, and fibrin deposition in serial 
biopsies are shown in Fig 1. In general , there was 
a progressive increase in inflammatory cells, 
erythrocytes, LCC, and fibrin over the 24 hr. 
In normal-appearing skin a few mononuclear 
cells were seen near blood vessels. The number of 
mononuclear cells was similar to the controls (see 
below). Polymorphonuclear cells and erythrocytes 
were absent. One hour after histamine injection 
the mononuclear cell population was increased 
modestly. Polymorphonuclear leukocytes (almost 
all neutrophils) and erythrocytes were seen in 
two patients. Four hours after histamine the· 
mononuclear cell population was increased in 4 
patients. Neutrophils were present in 4 patients, 
and erythrocytes were seen in 3. In 2 patients, 
LCC was seen for the first time. At 8 hr mononu-
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FIG 1. Sequential changes of cellular infiltration, 
leukocytoclasis, and fibrin deposition in serial biopsies 
from the study patients. Histamine provocations were 
done on each patient with biopsy at 1, 4. 8, and 24 hr. 
Parameters were graded as described in Table ll . 
MONO = mononuclear cells. PMNL = polymorphonu-
clear leukocytes (neutrophils). RBC = erythrocytes. 
LCC = leukocytoclasis. 
clear cells persisted in the 4 patients. neutrophils 
and LCC were present in these 4, and erythrocytes 
were seen in 3 (Fig 2). Twenty-four how-s after 
histamine a variable amount of infiltrate was still 
present. In the spontaneous lesions, an infiltrate 
of mononuclear cells, neutrophils, and RBCs was 
present in the 5 patients. There was no strict 
correspondence between the infiltrates seen after 
histamine and those in the spontaneous skin le-
sions. 
Controls. The sequential histologic changes in 
the three normal controls are shown in Fig. 3. As 
compared with most of the study patients. there 
was considerably less inflammatory change. 
l mmunoreactants Seen by Immunofluorescence 
Patients. The sequential changes of immuno-
globulins and C3 are shown in Fig 4. lgG was not 
seen in any biopsies. This was apparently not due 
to ineffective IgG-conjugate. as it regularly dem-
onstrated a positive band test in patients with 
SLE. In contrast with other batches of anti-IgG 
used in other patients, there was no appreciable 
"nonspecific" background staining of tissues. In 
general , there was an increase in the immunoreac-
tants which occurred 1 to 4 hr after histamine. In 
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FIG 2. Vessel in upper dennis of histamine-injected site from patient E biopsied at 8 hr showing mononuclear 
leukocytes <MNL ), neutrophils (N ), leukocytoclasis (arrows), and RBCs. Azure II, methylene blue, and basic 
fuschin stain (reduced from x 1000 4.7 enlargement). 
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FIG 3. Sequential changes of cellular infiltration, 
leukocytoclasis (LCC), electron-dense deposits (Edd), 
and fibrin deposition in ser ial biopsies from 3 healthy 
volunteers. Histamine injections were done on each 
patient with biopsy at 1 and 4 hr. Parameters were 
graded as described in Table II. 
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FIG 4. Sequential changes of imrnunoreactants in 
serial biopsies from the study patients. Histamine 
injections were done on each patient with biopsy at 1, 
4, 8, and 24 hr. Each parameter was graded on a scale 
of 0-4 +. Edd = electron-dense depos.its. 
contrast to the cellular changes, immunoreactants 
decreased at 8 and 24 hr. 
Each patient had either Igor C3 or both in the 
normal-appearing skin (0 hr). In three patients, 
either new immunoreactants appeared after his-
tamine, previously present immunoreactants in-
creased in quantity, or both of these changes 
occurred (Fig 5-l br, Fig 6-24 hr). The only 
exception to the early appearance of immunoreac-
tants is the late increase in IgM seen in patient 
C. The most dramatic overall changes were seen 
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in patient E where sharp increases in lgA, IgM, 
and C3 were present at 1 h.r and diminished 
thereafter. No significant changes occurred in 
patients A and B. lmmunoreactants were seen in 
the spontaneous lesions from 4 of the 5 patients. 
lgM was present in three patients, IgA in 1, and 
C3 was seen in 4. 
Controls. l mmunoreactants were not seen in 
FIG 5. Vessels in upper dermis of histamine-injected 
site from patient E biopsied at 1 hr showing intense 
staining for C3 (reduced from X400. 4.7 enlargement). 
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normal skin (Q hrl or histamine-injected sites in 
healthy controls at 1 or 4 hr. 
Ultrastructural Changes Seen by Electron 
Microscopy 
Patients. Cellular changes and fibrin deposition 
paralleled those seen by light microscopy. In ad-
FIG 6. Vessels in upper dermis of histamine-injected 
site from patient E biopsied at 24 hr showing small 
a mounts of material staining for C3, most of which 
appears to be in cells (reduced from x 400, 4. 7 enlarge-
ment). 
FIG 7. Electronmicrograph of a postcapillary venule from an histamine-injected site from patient E biopsied at 
1 hr showing electron-dense deposits (X). E = endothelial cell , BL = basal lami na, PMN = polymorphonuclear 
neutrophil (reduced from x 10,000, 3 enlargement). 
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dition, amorphous Edd characteristic of immune 
reactants !29,31] were seen in specimens from 2 
patients. The sequential changes of these deposits 
are shown in Fig 4. Edd were most prominent in 
histamine-injected sites at 1 and 4 hr (Fig 7-1 
hr). They were found between endothelial cells 
and pericytes on the luminal side of the vascular 
basement membrane. These deposits lacked the 
periodicity characteristic of fibrin [29]. 
The only vessels involved were postcapillary 
venules located predominantly in the upper half 
of the dermis. 
Controls. Cellular changes were minimal and 
paralleled those seen by light microscopy. No Edd 
were seen (Fig 3). 
DISCUSSION 
The most commonly held hypothesis about the 
pathogenesis of LCV is that this syndrome is 
caused by inflammation around blood vessels sec-
ondary to deposition of immune complexes fol-
lowed by complement activation [23]. The reasons 
for this presumption are stated in the introduction 
of this paper. We have also outlined the reasons 
why the relationship between LCV and immune 
complex deposition is not clear. We believe that 
the most likely reason why immunoreactants have 
not always been found in skin lesions of LCV is 
that the lesions biopsied were "old," i.e. , were 
present in the skin for more than 18-48 hr. By 
this time inflammatory cells may sti11 bp prP.sent. 
but immunoreactants may have disappeared due 
to natural "cleaning out"' processes of the inflam-
matory cells 124]. 
The purpose of this study was to examine the 
evolution of LCV dw·ing the controlled production 
of lesions using sequential biopsies of multiple 
histamine-injected skin sites. In this way, we 
could evaluate the presence of cells and immuno-
reactants in "'spontaneous" lesions (of unknown 
age), in normal-appearing skin and at known 
times after injection of histamine- a vasoactive 
amine which may be important in augmenting 
deposition of immune complexes [28]. By looking 
at biopsies before and at 1, 4, 8, and 24 hr after 
histamine injection, we might answer the follow-
ing questions. First. what are the kinetics of 
appearance and disappearance of immunoreac-
tants and cells at various times after histamine 
provocation? Second, what is the relationship be-
tween immunoreactants and cells present in nor-
mal-appearing skin vs. spontaneous lesions of 
varying ages vs. histamine-injected sites? 
All patients with LCV had immunoreactants 
present in normal-appearing skin, as has been 
previously reported 123,29]. ln 3 of our 5 patients, 
the injection of histamine was followed by the 
rapid appearance of new immunoreactants or an 
increase in the intensity of staining of immuno-
reactants already present. These changes in im-
munoglobulins and C3 were most prominent at 1 
and 4 hr and decreased thereafter (except for lgM 
in patient C). While none of the patients had Edd 
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in normal-appearing skin, these deposits were 
seen at 1 hr in 2 patients, and in these cases Edd 
also disappeared or diminished afterward. The 
fact that significant changes in Ig, C3, or Edd did 
not occur in patients A and B indicates that 
histamine injection does not provoke the accumu-
lation of immunoreactants in all vasculitis pa-
tients. The reasons for this are not clear at pres-
ent, but it should be noted that patient B had the 
least "active" clinical picture of vasculitis and, 
indeed, was on his way to spontaneous recovery. 
The histologic picture in normal-appearing skin 
in all 5 LCV patients was normal; the few mono-
nuclear cells seen were no different from those 
seen in normal volunteers. In 4 of the 5 LCV 
patients the injection of histamine was followed 
by the apperance of inflammatory cell infiltrates, 
beginning at 1 hr. These inflammatory infiltrates 
were mixed and contained both mononuclear and 
polymorphonuclear leukocytes (neutrophils). Al-
though precise quantitation is difficult, the data 
in Fig 1 show that the cellular infiltrate and 
fibrin deposition were most prominent at 8 and 24 
hr. LCV was seen in these 4 patients but not 
until 4 to 8 hr after histamine. Thus, all of the 
histologic features of LCV were induced by hista-
mine injection, beginning at 1 hr but peaking at 
8-24 hr. 
Control subjects injected with histamine showed 
only a few inflammatory cells and no visible 
JP.sions consistent with LCV. No immunoreactants 
were seen in skin biopsies at 0, 1, or 4 hr-times 
when the greatest amounts of immunoteactants 
were seen in LCV patients. Thus, we are confident 
that the histamine-provoked appearances of im-
munoreactants and signiiicant cellular infiltra-
tions in some of the LCV patients are abnormal 
findings. 
The location of the changes, most clearly seen 
by EM, was in blood vessels with the size and 
character of postcapillary venules. The postcapil-
lary venules were the only portion of the microcir-
culation involved. These are rnic:rovessels with a 
diameter of 8-30 /-f.ID which are continuous with 
venous capillaries. They are characterized by nu-
merous pericytes, a rnultilaminated basement 
membrane and a paucity of smooth muscle cells. 
These venules are the most common vessels in 
the papillary dermis. A gradient of increasing 
vascular permeability exists which begins in the 
arterioles, reaches a peak in the postcapiJlary 
venule, and then decreases gradually along the 
veins [32]. Therefore, if the inflammatory changes 
in LCV are due to deposition of immunoreactants, 
it is not surprising to find these changes in the 
most permeable part of the microvasculature; i.e., 
the postcapillary venule. 
It is much more difficult to answer the second 
question; i.e. , what is the relationship between 
im.munoreactants and cells in normal-appearing 
skin vs. spontaneous lesions vs. histamine-in-
jected sites of various ages? A number of points 
emerge in such an analysis. First , there is no 
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characteristic pattern of immunoreactants and 
cells either in spontaneous lesions or induced 
lesions. This was a disappointing finding because 
it prevents us from "dating" spontaneous lesions 
by comparing them to induced lesions of known 
age. Second, the patterns of inflammatory cells in 
the induced lesions change in a given patient as a 
function of time. It was particularly difficult to 
make generalizations as to whether mononuclear 
cells or neutrophils predominated. 
For instance, patient C had more mononuclear 
cells early but equal numbers of mononuclear 
cells and neutrophils at 24 hr. Conversely, patient 
D had a relative predominance of neutrophils at 1 
and 4 hr but a more equal distribution of cells at 8 
and 24 hr. Perhaps most instructive is patient E 
who had both types of cells present at 4 and 8 hr 
but only neutrophils at 24 hr. The outstanding 
featw·es of these biopsies are, in fact, the diversity 
of changes in different patients at different times. 
Soter and his colleagues have reported that 
there are 2 distinct cellular patterns in cutaneous 
necrotizing vasculitis [33]. In patients with hypo-
complementemia, there was a perivascular infil-
trate composed primarily of neutrophils. In pa-
tients with normal serum complement levels, in 
addition to infiltrating neutrophils, perivenular 
lymphocytes were prominent. Our 5 patients had 
essentially normal CH511 levels, and when comple-
ment components were assayed only 1 component 
in each of 2 patients was slightly low. Neverthe-
less. the spontaneous lesions and the histamine-
incuded lesions did not show a distinct pattern of 
cellular infiltrate. Virtually all lesions contained 
both neutrophils and mononuclear cells. and the 
relative proportions varied, not only from patient 
to patient but also in the same patient. 
In spite of our agreement with Soter and col-
leagues that LCV includes a heterogeneous group 
of patients and a number of mechanisms, we 
believe that our data do not support the division 
into two distinct histologic pictures. Rather, we 
believe that a variety of histologic characteristics 
will be seen depending on the age of the evolving 
vasculitis process and on other as yet unknown 
factors. 
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